missing translation for 'onlineSavingsMsg'
Learn More
Learn More
enQuireBio™ Recombinant Mouse Leptin tA Protein
A cDNA sequence encoding the Leptin tA was constructed and used to recombinantly synthesize the protein.
120.00€ - 181.00€
Specifica
Nome | Leptin tA Protein |
---|---|
Purezza | Greater than 99.0% as determined by:(a) Gel filtration analysis. (b) Analysis by SDS-PAGE. |
Status giuridico | Research Use Only |
Concentrazione di endotossine | < 1.0 EU per ug protein as determined by the LAL method. |
Attività biologica | Leptin Antagonist Triple Mutant Mouse Recombinant half-life in circulation after SC injection was over 20 hours. Leptin Antagonist Triple Mutant Mouse Recombinant is capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. Leptin Antagonist Triple Mutant Mouse Recombinant in vitro activity is 5-6 fold lower than the non-pegylated antagonist, though in vivo it has profound weight gain effect (as compared to the non-pegylated antagonist), resulting mainly from increased food intake. |
Codice del prodotto | Marca | Quantità | Prezzo | Quantità e disponibilità | |||||
---|---|---|---|---|---|---|---|---|---|
Codice del prodotto | Marca | Quantità | Prezzo | Quantità e disponibilità | |||||
15945098
|
enQuireBio™
QP10764-5UG |
5 μg |
120.00€
5µg |
Eseguire il login per visualizzare lo stock disponibile |
15935098
|
enQuireBio™
QP10764-20UG |
20 μg |
181.00€
20µg |
Eseguire il login per visualizzare lo stock disponibile |
Specifica
Leptin tA Protein | |
Research Use Only | |
Leptin Antagonist Triple Mutant Mouse Recombinant half-life in circulation after SC injection was over 20 hours. Leptin Antagonist Triple Mutant Mouse Recombinant is capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. Leptin Antagonist Triple Mutant Mouse Recombinant in vitro activity is 5-6 fold lower than the non-pegylated antagonist, though in vivo it has profound weight gain effect (as compared to the non-pegylated antagonist), resulting mainly from increased food intake. | |
Mouse | |
Untagged |
Greater than 99.0% as determined by:(a) Gel filtration analysis. (b) Analysis by SDS-PAGE. | |
< 1.0 EU per ug protein as determined by the LAL method. | |
Recombinant Protein | |
E. coli | |
The Mouse Leptin triple antagonist was lyophilized from a concentrated (0.65 mg/ml) solution with 0.003mM NaHCO3. |